Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Margolin

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Expert Opinion on Biological Therapy|September 9, 2008
Cytokine therapy in cancerKim Margolin
Current Oncology Reports|August 11, 2005
Mitotic rate and younger age as predictors of sentinel lymph node positivityKim Margolin
Current Oncology Reports|August 11, 2005
Molecular staging in stage II and III melanoma patientsKim Margolin
Lancet (London, England)|June 28, 2012
BRAF inhibition and beyond in advanced melanomaKim Margolin
Current Oncology Reports|August 12, 2006
Clinical trials report. Sun exposure and mortality from melanomaKim Margolin
ESMO Open|November 2, 2019
What is new on the horizon in melanoma brain metastasis?Kim Margolin
Oncoimmunology|November 22, 2012
Ipilimumab in a Phase II trial of melanoma patients with brain metastasesKim Margolin
Current Treatment Options in Oncology|July 28, 2016
The Promise of Molecularly Targeted and Immunotherapy for Advanced MelanomaKim Margolin
The Journal of Urology|March 12, 2003
High dose chemotherapy and stem cell support in the treatment of germ cell cancerKim Margolin
Current Oncology Reports|October 6, 2007
Sentinel-node biopsy or nodal observation in melanomaKim Margolin
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Expert Opinion on Biological Therapy|September 9, 2008
Cytokine therapy in cancerKim Margolin
Current Oncology Reports|August 11, 2005
Mitotic rate and younger age as predictors of sentinel lymph node positivityKim Margolin
Current Oncology Reports|August 11, 2005
Molecular staging in stage II and III melanoma patientsKim Margolin
Lancet (London, England)|June 28, 2012
BRAF inhibition and beyond in advanced melanomaKim Margolin
Current Oncology Reports|August 12, 2006
Clinical trials report. Sun exposure and mortality from melanomaKim Margolin
ESMO Open|November 2, 2019
What is new on the horizon in melanoma brain metastasis?Kim Margolin
Oncoimmunology|November 22, 2012
Ipilimumab in a Phase II trial of melanoma patients with brain metastasesKim Margolin
Current Treatment Options in Oncology|July 28, 2016
The Promise of Molecularly Targeted and Immunotherapy for Advanced MelanomaKim Margolin
The Journal of Urology|March 12, 2003
High dose chemotherapy and stem cell support in the treatment of germ cell cancerKim Margolin
Current Oncology Reports|October 6, 2007
Sentinel-node biopsy or nodal observation in melanomaKim Margolin
Pageof 10